Literature DB >> 24346710

Pulmonary manifestations of the pre-engraftment syndrome after umbilical cord blood transplantation.

Kyle R Brownback1, Steven Q Simpson, Joseph P McGuirk, Tara L Lin, Sunil Abhyankar, Siddhartha Ganguly, Omar S Aljitawi.   

Abstract

Pre-engraftment syndrome (PES) is a condition occurring after umbilical cord blood transplantation (UCBT) characterized by fever and erythematous skin rash prior to neutrophil engraftment. We sought to determine the incidence and characterize the pulmonary manifestations of PES. A retrospective review of patients who underwent UCBT at the University of Kansas Medical Center over a 5-year period was performed. Data collected included patient baseline characteristics, presence of PES, pulmonary findings, treatments, and survival. Forty-four patients underwent UCBT with 22 of those patients developing PES. Full-intensity myeloablative conditioning regimen was found to be a risk factor for development of PES. Of those 22 patients, 13 had resting hypoxemia. The most common radiographic findings included diffuse ground glass opacities with pleural effusions. Fifteen patients with PES received corticosteroids, of which 12 had improvement in fevers and rash. These patients had a trend toward worse mortality than those not receiving corticosteroids. There was a nonsignificant trend toward worse survival in patients with PES and hypoxemia compared to those without hypoxemia. PES is a common complication following cord blood transplantation, with hypoxemia being present in over half of patients with PES. Hypoxemia with PES and treatment with corticosteroids may portend a worse prognosis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24346710      PMCID: PMC4109706          DOI: 10.1007/s00277-013-1981-0

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  24 in total

1.  Clinical evidence for an engraftment syndrome associated with early and steep neutrophil recovery after autologous blood stem cell transplantation.

Authors:  C Ravoet; W Feremans; B Husson; F Majois; A Kentos; M Lambermont; G Wallef; P Capel; M Beauduin; A Delannoy
Journal:  Bone Marrow Transplant       Date:  1996-11       Impact factor: 5.483

Review 2.  Bronchoalveolar lavage constituents in healthy individuals, idiopathic pulmonary fibrosis, and selected comparison groups. The BAL Cooperative Group Steering Committee.

Authors: 
Journal:  Am Rev Respir Dis       Date:  1990-05

3.  Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome.

Authors:  Roy G Brower; Michael A Matthay; Alan Morris; David Schoenfeld; B Taylor Thompson; Arthur Wheeler
Journal:  N Engl J Med       Date:  2000-05-04       Impact factor: 91.245

4.  Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia.

Authors:  Vanderson Rocha; Myriam Labopin; Guillermo Sanz; William Arcese; Rainer Schwerdtfeger; Alberto Bosi; Niels Jacobsen; Tapani Ruutu; Marcos de Lima; Jürgen Finke; Francesco Frassoni; Eliane Gluckman
Journal:  N Engl J Med       Date:  2004-11-25       Impact factor: 91.245

5.  Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia.

Authors:  Mary J Laughlin; Mary Eapen; Pablo Rubinstein; John E Wagner; Mei-Jei Zhang; Richard E Champlin; Cladd Stevens; Juliet N Barker; Robert P Gale; Hillard M Lazarus; David I Marks; Jon J van Rood; Andromachi Scaradavou; Mary M Horowitz
Journal:  N Engl J Med       Date:  2004-11-25       Impact factor: 91.245

6.  Pre-engraftment syndrome after myeloablative dual umbilical cord blood transplantation: risk factors and response to treatment.

Authors:  J Kanda; L Kaynar; Y Kanda; V K Prasad; S H Parikh; L Lan; T Shen; D A Rizzieri; G D Long; K M Sullivan; C Gasparetto; J P Chute; A Morris; S Winkel; J McPherson; J Kurtzberg; N J Chao; M E Horwitz
Journal:  Bone Marrow Transplant       Date:  2013-01-21       Impact factor: 5.483

Review 7.  Hepatic veno-occlusive disease (sinusoidal obstruction syndrome) after hematopoietic stem cell transplantation.

Authors:  Shaji Kumar; Laurie D DeLeve; Patrick S Kamath; Ayalew Tefferi
Journal:  Mayo Clin Proc       Date:  2003-05       Impact factor: 7.616

8.  Engraftment syndrome in autologous bone marrow and peripheral stem cell transplantation.

Authors:  C K Lee; R D Gingrich; R J Hohl; K A Ajram
Journal:  Bone Marrow Transplant       Date:  1995-07       Impact factor: 5.483

Review 9.  Acute cardiogenic pulmonary edema.

Authors:  M A Gropper; J P Wiener-Kronish; S Hashimoto
Journal:  Clin Chest Med       Date:  1994-09       Impact factor: 2.878

10.  Engraftment syndrome following autologous hematopoietic stem cell transplantation: definition of diagnostic criteria.

Authors:  A Maiolino; I Biasoli; J Lima; A C Portugal; W Pulcheri; M Nucci
Journal:  Bone Marrow Transplant       Date:  2003-03       Impact factor: 5.483

View more
  6 in total

Review 1.  Engraftment syndrome: double-edged sword of hematopoietic cell transplants.

Authors:  T R Spitzer
Journal:  Bone Marrow Transplant       Date:  2015-01-12       Impact factor: 5.483

2.  TNF-receptor inhibitor therapy for the treatment of children with idiopathic pneumonia syndrome. A joint Pediatric Blood and Marrow Transplant Consortium and Children's Oncology Group Study (ASCT0521).

Authors:  Gregory A Yanik; Stephan A Grupp; Michael A Pulsipher; John E Levine; Kirk R Schultz; Donna A Wall; Bryan Langholz; Christopher C Dvorak; Keith Alangaden; Rakesh K Goyal; Eric S White; Jennifer M Collura; Micah A Skeens; Saada Eid; Elizabeth M Pierce; Kenneth R Cooke
Journal:  Biol Blood Marrow Transplant       Date:  2014-09-28       Impact factor: 5.742

3.  Engraftment syndrome after allogeneic hematopoietic cell transplantation predicts poor outcomes.

Authors:  Lawrence Chang; David Frame; Thomas Braun; Erin Gatza; David A Hanauer; Shuang Zhao; John M Magenau; Kathryn Schultz; Hemasri Tokala; James L M Ferrara; John E Levine; Pavan Reddy; Sophie Paczesny; Sung Won Choi
Journal:  Biol Blood Marrow Transplant       Date:  2014-06-02       Impact factor: 5.742

4.  Increased mortality in hematological malignancy patients with acute respiratory failure from undetermined etiology: a Groupe de Recherche en Réanimation Respiratoire en Onco-Hématologique (Grrr-OH) study.

Authors:  Adrien Contejean; Virginie Lemiale; Matthieu Resche-Rigon; Djamel Mokart; Frédéric Pène; Achille Kouatchet; Julien Mayaux; François Vincent; Martine Nyunga; Fabrice Bruneel; Antoine Rabbat; Pierre Perez; Anne-Pascale Meert; Dominique Benoit; Rebecca Hamidfar; Michael Darmon; Mercé Jourdain; Anne Renault; Benoît Schlemmer; Elie Azoulay
Journal:  Ann Intensive Care       Date:  2016-10-25       Impact factor: 6.925

Review 5.  Pre-engraftment syndrome: clinical significance and pathophysiology.

Authors:  Young-Ho Lee; Wee-Jin Rah
Journal:  Blood Res       Date:  2016-09-23

6.  Inflammatory monocytes promote pre-engraftment syndrome and tocilizumab can therapeutically limit pathology in patients.

Authors:  Linlin Jin; Zimin Sun; Huilan Liu; Xiaoyu Zhu; Yonggang Zhou; Binqing Fu; Xiaohu Zheng; Kaidi Song; Baolin Tang; Yun Wu; Jiang Zhu; Rui Sun; Zhigang Tian; Haiming Wei
Journal:  Nat Commun       Date:  2021-07-06       Impact factor: 14.919

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.